96010 Integrated Therapeutics 26cp; 1 x 3hpw (supporting learning activities e.g. lectures, online modules), 2 x 2hpw (workshop)
Requisite(s): 96006 Integrated Therapeutics 1 AND 96005 Professional Services 2 AND 96007 Drug Disposition AND 96008 Evidence-based Practice
These requisites may not apply to students in certain courses.
There are course requisites for this subject. See access conditions.
Building on 96006 Integrated Therapeutics 1, this subject focuses on the optimal use of pharmacotherapy in the management of neurologic, endocrine, rheumatologic, ophthalmic, dermatologic and mental health disorders. The epidemiology, pathophysiology, diagnosis and clinical presentation of illness and disease are reviewed. Using an integrated approach, treatment and management options are considered with reference to relevant pharmacology, medicinal chemistry, formulation, pharmacokinetics and clinical properties of targeted therapies.
This subject contributes to the Master of Pharmacy by providing students with the knowledge and skills to optimise pharmacotherapy and clinical management of illness and disease.
Autumn session, City campus
Detailed subject description.